Connect with Us
602 Park Point Drive, Suite 225, Golden, CO 80401 – +1 303.495.2073
© 2025 Medical Affairs Professional Society (MAPS). All Rights Reserved Worldwide.
Stephen Towers, PhD
SVP, Medical Affairs Strategy & Transformation, HCG
The ever-increasing pressure on Medical Affairs organizations to demonstrate the impact of their activities has spawned unprecedented efforts to develop content and programs that are likely to be effective and to deliver a return on investment. This new era of evidence-based medical communications manifests most obviously in data-backed efforts to (1) address the knowledge needs of different audiences (with a reach goal of individual HCP-level personalization), (2) provide content in formats and via channels aligned to audience preferences, and (3) leverage principles of adult learning where possible. However, a major piece of the puzzle that’s often missing is storytelling—namely, the extent to which a narrative style is deployed and the effectiveness of the resulting narratives. “Not storytelling,” you may insist. “Isn’t that one of the most omnipresent buzzwords of our age?” We agree that storytelling has become something of a “bumper sticker.” But how often in the world of pharmaceutical industry-developed medical communications is there anything of substance behind the bumper sticker? Like a bumper. Or even a fully intact car to transport you to another destination, as good storytelling should? In short, and to borrow from the most legendary of storytellers, Hans Christian Andersen, is it possible that the emperor has no…narratives?
A true evidence-based approach to medical communications must give more than lip service to storytelling because it’s associated with numerous benefits over more expository styles of communication for education and knowledge transfer.1-3 A wealth of data indicates that we are neurologically predisposed to focus on content presented in a story format.4 Given the immense volume of new data, the limited time that HCPs have to keep up with new information and the soaring complexity of medical science (novel therapeutic modalities, complex patient journeys, etc), isn’t it time to remind ourselves that HCPs are humans too and provide them—and their patients—with content crafted in a narrative style that resonates on a human level?
Imagine a scenario in which we developed educational content for an HCP that aligned with her clinical interests, was packaged into an appealing format (eg, animated video), and was delivered via one of her preferred channels, but it contained a subpar story? It should be obvious that all the exciting technologies, striking visuals, or novel formats in the world won’t rescue a story that’s poorly constructed, ill conceived, lacking in credibility, or boring. So, how can we develop effective stories in Medical Affairs? Before answering that question, we must define what we mean by “effective”—essentially, what do we want our stories to achieve? An effective story is often considered to be one that is:
Obviously, these goals are heavily interconnected and interdependent. If your story falls at the first hurdle (grabbing attention), it’s clearly game over for everything else. Importantly, research also indicates that narratives are stripped of their power to persuade and be remembered if the audience is not sufficiently engaged.7 To craft a story that achieves some or all these goals, we can tap into a large and growing body of research, with an evidence base that draws from diverse disciplines, including psychology, linguistics, sociology, pedagogy, and cognitive science. As a proponent of evidence-based medical communications, our team of scientists and narrative experts has reviewed data from across those disciplines to create a simple framework for Medical Affairs storytelling excellence that includes seven key considerations (see Figure 1).
Figure 1. STORIES: An evidence-based framework for storytelling excellence includes seven key considerations for effective, purpose-driven stories.
We’ll now examine how some of the key considerations from our evidence-based framework have been practically applied to create stories for diverse Medical Affairs external audiences.
According to the MAPS white paper, “The Future of Medical Affairs 2030,” Medical Affairs will increasingly “own the scientific aspects of patient engagement.”47 Yet, the task of adequately equipping patients and caregivers with an understanding of their disease and empowering them to actively participate in shared decision-making with their providers is no small feat. The three major challenges are low (albeit varying) degrees of scientific literacy in the population at large, the increasing complexity of novel therapies, and the often-suboptimal nature of HCP–patient communications. Regarding the latter, it’s not uncommon that even HCPs with a solid grasp of the science can struggle to educate or counsel their patients on complex concepts.48-50 Perhaps it’s not surprising then that the content HCPs value most from pharmaceutical companies—according to several surveys —is medical content they can use with their patients.51,52 Thankfully, there’s considerable evidence to indicate that content provided in a narrative form can be particularly effective for patient and caregiver audiences, including for communicating and contextualizing risk, changing health behaviors, and fostering empathy and understanding of patients among providers.53-56
Shown in Figure 2 is an example of a graphic novel–style patient journey story we created to educate patients with cognitive impairment associated with schizophrenia (CIAS) and their caregivers about the illness. The aim of this resource was to make patients feel “seen” and counter the internalized stigma that may prevent them from mentioning to their HCPs how severely they are impacted by the cognitive symptoms. To achieve this, we created the life story of a fictional patient named Tom—based on a composite of several patients’ experiences. This format was designed to leverage the storytelling technique of identification, mentioned earlier, to increase the engagement of our target audience. A companion version of Tom’s story was created for HCPs, with additional clinical details, data, and references to support each narrative frame. With this version, our goal was to increase HCPs’ empathy and understanding of the burden that cognitive impairment imposes on so many aspects of their patients’ lives, thereby encouraging person-centered care. Though graphic novels are a relatively new medical communications format, they have already shown promise in a number of patient, caregiver, and HCP use cases.57-59
Figure 2. Innovative, graphic novel–style disease education resource to educate patients and caregivers (TAILORING, RATIONALITY, EMOTIONALITY)
Creating a simple, clinically meaningful mechanism of disease story or MOA story for a novel therapy is not easy. Partly, this is due to the immense complexity of biological pathways and processes, as well as mechanisms of new therapies. Another enemy of a simple story that’s all too common is a state of uncertainty, such as an incomplete or evolving understanding of the science.60 Perhaps the most significant challenge we face, however, is that human cognition has evolved in a way that biases us toward understanding “human-scale” objects that can be easily observed (eg, a tree), rather than micro- or nanoscale objects (eg, a 150-nm virus) or cosmic-scale objects (eg, black holes).61
One response to these challenges within a narrative is to deploy metaphors or similes.62 Metaphors can create powerful mental images that provide a frame of reference for an abstract or unfamiliar concept by bridging it to the concrete or familiar.63 Metaphors are ubiquitous in science for making complex concepts more accessible, and they’re frequently used in HCP–patient conversations. Indeed, one study found that oncologists include, on average, at least one metaphor in each conversation they have with patients who have advanced cancer.64
A recent project to create a clinically meaningful MOA narrative for an ulcerative colitis therapy provides a good example. The immunology underlying chronic inflammatory diseases is complex, but we sought to make the complex science accessible, memorable, and relatable. The therapy acts by reducing the trafficking of some specific types of immune cells to the site of inflammation. We partnered with our clients to develop a simple metaphor that likened cell trafficking in ulcerative colitis to vehicle traffic in a complex urban environment; consider the cells as cars, each on a journey to a specific destination, analogous to immune cells travelling around the body to sites of inflammation, injury, or infection (Figure 3). This metaphor was used to illustrate the healthy state, untreated disease, and the impact of the new therapy on reducing traffic to inflamed sites, while retaining the ability to respond rapidly to infection or injury.
Figure 3. Visual storytelling and metaphors to translate complex science: Pfizer symposium at the 18th Congress of European Crohn’s and Colitis Organisation (ECCO), March 1-4, 2023 (ORIGINALITY, SIMPLICITY)
New technologies, such as virtual reality (VR), offer the potential for storytelling of an even greater intensity. With the ability to create 3D simulations of real-world objects, locations, and interactions, VR has already demonstrated significant potential for medical education, clinical skills training (eg, surgical training), and role-playing.65 We recently developed a VR patient case study simulator to educate physicians on post-infusion side effects of CAR T-cell therapy and equip them with the skills to manage them effectively (Figure 4). Up to 93% of patients with relapsing/remitting diffuse large B-cell lymphoma (DLBCL) can experience cytokine release syndrome (CRS) and neurologic side effects that require urgent and complex care following CAR T infusion. Through an immersive, real-time experience, we recreated the high-pressure, time-sensitive clinical environment in which treating physicians can hone their skills by reviewing patients’ medical history, monitoring patient vitals, and using treatment tools and consensus guidelines to make real-time life or death clinical decisions. At the heart of the experience were four distinct patient stories—two pediatric and two adult patients of varying CRS and neurotoxicity severity. We leveraged storytelling principles of tailoring and emotionality with the CAR T VR tool—the emotionality came from insights that the audience were reluctant to prescribe CAR T therapies based on a fear of how to manage the potential serious side effects of the early CAR Ts, and the tailoring came from how we designed it as an in-clinic experience and modelled the characters on the actual staff who would be involved in the delivery of care.
Figure 4. Immersive storytelling for HCP skills training: VR patient case simulator for post–CAR T-cell infusion management (TAILORING, EMOTIONALITY)
In the coming years, storytelling will become more interactive and immersive (shaped by extended reality [XR] technologies and AI), more personalized and participatory, and more collaborative. The basic properties that give stories their power will endure, but there will be a need for ongoing exploration and research into how each new medium and technology can be exploited to create and deliver the most effective stories for our audiences. Though the pace of change may seem daunting, Medical Affairs organizations should feel reassured that they are broadly aligned with many of the emerging goals of our function, including the need to provide a broader range of stakeholders with personalized, clinically useful content.
602 Park Point Drive, Suite 225, Golden, CO 80401 – +1 303.495.2073
© 2025 Medical Affairs Professional Society (MAPS). All Rights Reserved Worldwide.